Explore the latest books of this year!
Bookbot

IARC Scientific Publications - 154: Biomarkers in Cancer Chemoprevention

More about the book

The evaluation of potential cancer chemopreventive agents require large, long-term, randomized trials in humans. Biomarkers that would allow the identification of subjects exposed to carcinogenic agents, or of individuals genetically, susceptible to cancer would be of great value. This volume is the product of an attempt to assess current knowledge and experience with the use of biomarkers in cancer chemoprevention. It comprises an expert report on the current state of the art use of biomarkers in cancer chemoprevention, introductory sections covering general topics in cancer chemoprevention, and contributions, directed to biomarkers of exposure, intermediate effect and susceptibility relating to six major cancer sites: skin, colorectum, breast, prostate, liver, and upper aerodigestive tract.

Book purchase

IARC Scientific Publications - 154: Biomarkers in Cancer Chemoprevention, Anthony B. Miller, Hella Bartsch, Paolo Boffetta, L Dragsted, H. Vainio

Language
Released
2001
product-detail.submit-box.info.binding
(Paperback),
Book condition
Damaged
Price
€24.07

Payment methods

No one has rated yet.Add rating

Title
IARC Scientific Publications - 154: Biomarkers in Cancer Chemoprevention
Language
English
Released
2001
Format
Paperback
Pages
304
ISBN10
9283221540
ISBN13
9789283221548
Series
Description
The evaluation of potential cancer chemopreventive agents require large, long-term, randomized trials in humans. Biomarkers that would allow the identification of subjects exposed to carcinogenic agents, or of individuals genetically, susceptible to cancer would be of great value. This volume is the product of an attempt to assess current knowledge and experience with the use of biomarkers in cancer chemoprevention. It comprises an expert report on the current state of the art use of biomarkers in cancer chemoprevention, introductory sections covering general topics in cancer chemoprevention, and contributions, directed to biomarkers of exposure, intermediate effect and susceptibility relating to six major cancer sites: skin, colorectum, breast, prostate, liver, and upper aerodigestive tract.